2014 Speakers

CHAIRPERSON: William K. Schmidt, Ph.D., President, NorthStar Consulting, LLC, VP Clinical & Regulatory, Centrexion Corp., VP Clinical & Regulatory, Cap Genesis, LLC, VP Clinical Development, EicOsis, LLC

Jon Levine, MD, Ph.D., Professor of Medicine, University of California, San Francisco

Anthony Ford, Ph.D., Chief Scientific Officer, Afferent Pharmaceuticals

Thomas Kornecook, Ph.D., Principal Scientist, Department of Neuroscience, Amgen, Inc.

Doo Lee, Ph.D., Chief Executive Officer, Vivozon

Ed Bilsky, Ph.D., Professor of Pharmacology, COM, Vice President of Research and Scholarship, University of New England

Steve Harrison, Ph.D., Vice President, Research Biology, Nektar Therapeutics

David Yeomans, Ph.D., Director of Pain Research, Faculty of Anesthesia, Stanford University School of Medicine, Founder & Chief Scientist, Trigemina, Inc.

Cheryl Hankin, Ph.D., President and Chief Scientific Officer, BioMedEcon, LLC

Leon Garcia-Martinez, Ph.D., Senior Director Target Biology, Alder Biopharmaceuticals

Theodore Price, Ph.D., Associate Professor, School of Behavioral and Brain Sciences, University of Texas at Dallas

Gaetano Scuderi, MD, Founder, President, Cytonics Corporation

Nader Ghasemlou, Ph.D., Research Fellow, Children's Hospital Boston & Harvard Medical School, F.M. Kirby Neurobiology Center

Neil Singla, MD, Founder & Chief Scientific Officer, Lotus Clinical Research

Mike Royal, MD, JD, MBA, Executive VP, Clinical & Regulatory Affairs, Sorrento Therapeutics, Inc.

Ernest A. Kopecky, Ph.D., MBA, VP Clinical Development | Head, Neuroscience TA, COLLEGIUM Pharmaceutical

Lee M. Techner, DPM, Principal and Chief Clinical Consultant, Stage Gate Partners

Daniel Legault, JD, Chief Executive Officer and Director, Antibe Therapeutics

Brian Meshkin, Founder and President, Proove Biosciences